267 related articles for article (PubMed ID: 32311201)
1. iStent inject trabecular micro-bypass stents with topical prostaglandin as standalone treatment for open-angle glaucoma: 4-year outcomes.
Berdahl J; Voskanyan L; Myers JS; Katz LJ; Samuelson TW
Clin Exp Ophthalmol; 2020 Aug; 48(6):767-774. PubMed ID: 32311201
[TBL] [Abstract][Full Text] [Related]
2. Prospective Evaluation of Two iStent
Myers JS; Masood I; Hornbeak DM; Belda JI; Auffarth G; Jünemann A; Giamporcaro JE; Martinez-de-la-Casa JM; Ahmed IIK; Voskanyan L; Katz LJ
Adv Ther; 2018 Mar; 35(3):395-407. PubMed ID: 29476443
[TBL] [Abstract][Full Text] [Related]
3. Five-Year Outcomes Prospective Study of Two First-Generation Trabecular Micro-Bypass Stents (iStent®) in Open-Angle Glaucoma.
Saheb H; Donnenfeld ED; Solomon KD; Voskanyan L; Chang DF; Samuelson TW; Ahmed IIK; Katz LJ
Curr Eye Res; 2021 Feb; 46(2):224-231. PubMed ID: 32715828
[TBL] [Abstract][Full Text] [Related]
4. Implantation of two second-generation trabecular micro-bypass stents and topical travoprost in open-angle glaucoma not controlled on two preoperative medications: 18-month follow-up.
Berdahl J; Voskanyan L; Myers JS; Hornbeak DM; Giamporcaro JE; Katz LJ; Samuelson TW
Clin Exp Ophthalmol; 2017 Nov; 45(8):797-802. PubMed ID: 28384377
[TBL] [Abstract][Full Text] [Related]
5. Five-Year, Prospective, Randomized, Multi-Surgeon Trial of Two Trabecular Bypass Stents versus Prostaglandin for Newly Diagnosed Open-Angle Glaucoma.
Fechtner RD; Voskanyan L; Vold SD; Tetz M; Auffarth G; Masood I; Au L; Khouri AS; Ahmed IIK; Saheb H
Ophthalmol Glaucoma; 2019; 2(3):156-166. PubMed ID: 32672584
[TBL] [Abstract][Full Text] [Related]
6. Second-Generation Trabecular Micro-Bypass Stents as Standalone Treatment for Glaucoma: A 36-Month Prospective Study.
Hengerer FH; Auffarth GU; Riffel C; Conrad-Hengerer I
Adv Ther; 2019 Jul; 36(7):1606-1617. PubMed ID: 31119690
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of two trabecular micro-bypass stents combined with topical travoprost in open-angle glaucoma not controlled on two preoperative medications: 3-year follow-up.
Chang DF; Donnenfeld ED; Katz LJ; Voskanyan L; Ahmed II; Samuelson TW; Giamporcaro JE; Hornbeak DM; Solomon KD
Clin Ophthalmol; 2017; 11():523-528. PubMed ID: 28352151
[TBL] [Abstract][Full Text] [Related]
8. One-Year Comparative Evaluation of iStent or iStent inject Implantation Combined with Cataract Surgery in a Single Center.
Guedes RAP; Gravina DM; Lake JC; Guedes VMP; Chaoubah A
Adv Ther; 2019 Oct; 36(10):2797-2810. PubMed ID: 31440981
[TBL] [Abstract][Full Text] [Related]
9. iStent inject Trabecular Micro-Bypass with or Without Cataract Surgery Yields Sustained 5-Year Glaucoma Control.
Hengerer FH; Auffarth GU; Conrad-Hengerer I
Adv Ther; 2022 Mar; 39(3):1417-1431. PubMed ID: 35113323
[TBL] [Abstract][Full Text] [Related]
10. Four-Year Outcomes of Two Second-Generation Trabecular Micro-Bypass Stents in Patients with Open-Angle Glaucoma on One Medication.
Lindstrom R; Sarkisian SR; Lewis R; Hovanesian J; Voskanyan L
Clin Ophthalmol; 2020; 14():71-80. PubMed ID: 32021070
[TBL] [Abstract][Full Text] [Related]
11. Minimally invasive glaucoma surgery: Comparison of iStent with iStent inject in primary open angle glaucoma.
Hooshmand J; Rothschild P; Allen P; Kerr NM; Vote BJ; Toh T
Clin Exp Ophthalmol; 2019 Sep; 47(7):898-903. PubMed ID: 31034687
[TBL] [Abstract][Full Text] [Related]
12. Outcomes Following Implantation of Two Second-Generation Trabecular Micro-Bypass Stents in Patients with Open-Angle Glaucoma on One Medication: 18-Month Follow-Up.
Lindstrom R; Lewis R; Hornbeak DM; Voskanyan L; Giamporcaro JE; Hovanesian J; Sarkisian S
Adv Ther; 2016 Nov; 33(11):2082-2090. PubMed ID: 27739003
[TBL] [Abstract][Full Text] [Related]
13. Standalone Implantation of 2-3 Trabecular Micro-Bypass Stents (iStent inject ± iStent) as an Alternative to Trabeculectomy for Moderate-to-Severe Glaucoma.
Paletta Guedes RA; Gravina DM; Paletta Guedes VM; Chaoubah A
Ophthalmol Ther; 2022 Feb; 11(1):271-292. PubMed ID: 34825352
[TBL] [Abstract][Full Text] [Related]
14. Long-term titrated IOP control with one, two, or three trabecular micro-bypass stents in open-angle glaucoma subjects on topical hypotensive medication: 42-month outcomes.
Katz LJ; Erb C; Carceller Guillamet A; Fea AM; Voskanyan L; Giamporcaro JE; Hornbeak DM
Clin Ophthalmol; 2018; 12():255-262. PubMed ID: 29440867
[TBL] [Abstract][Full Text] [Related]
15. Prospective, Randomized, Controlled Pivotal Trial of an Ab Interno Implanted Trabecular Micro-Bypass in Primary Open-Angle Glaucoma and Cataract: Two-Year Results.
Samuelson TW; Sarkisian SR; Lubeck DM; Stiles MC; Duh YJ; Romo EA; Giamporcaro JE; Hornbeak DM; Katz LJ;
Ophthalmology; 2019 Jun; 126(6):811-821. PubMed ID: 30880108
[TBL] [Abstract][Full Text] [Related]
16. Real-world Case Series of iStent or iStent inject Trabecular Micro-Bypass Stents Combined with Cataract Surgery.
Manning D
Ophthalmol Ther; 2019 Dec; 8(4):549-561. PubMed ID: 31422555
[TBL] [Abstract][Full Text] [Related]
17. 7-Year Efficacy and Safety of iStent inject Trabecular Micro-Bypass in Combined and Standalone Usage.
Hengerer FH; Auffarth GU; Conrad-Hengerer I
Adv Ther; 2024 Apr; 41(4):1481-1495. PubMed ID: 38363465
[TBL] [Abstract][Full Text] [Related]
18. Prospective, Non-randomized, 36-Month Study of Second-Generation Trabecular Micro-Bypass Stents with Phacoemulsification in Eyes with Various Types of Glaucoma.
Hengerer FH; Auffarth GU; Riffel C; Conrad-Hengerer I
Ophthalmol Ther; 2018 Dec; 7(2):405-415. PubMed ID: 30430427
[TBL] [Abstract][Full Text] [Related]
19. Second-Generation Trabecular Micro-Bypass (iStent inject) with Cataract Surgery in Eyes with Normal-Tension Glaucoma: One-Year Outcomes of a Multi-Centre Study.
Salimi A; Clement C; Shiu M; Harasymowycz P
Ophthalmol Ther; 2020 Sep; 9(3):585-596. PubMed ID: 32613589
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and Safety of Pairing iStent Inject Trabecular Micro-Bypass and iAccess Precision Blade Goniotomy in Patients with Open-Angle Glaucoma.
Gallardo MJ; Porter M
Ophthalmol Ther; 2023 Aug; 12(4):1973-1987. PubMed ID: 37178443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]